The latest study on Acute Myeloid Leukemia Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Acute Myeloid Leukemia Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Acute Myeloid Leukemia and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Abbvie
Astellas Pharma
CTI Biopharma Corp
Acute Myeloid Leukemia Market Analysis By Type Segment:
Chemotherapy
Radiation Therapy
Stem Cell Transplant
Targeted Therapy
Others
Acute Myeloid Leukemia Market Analysis By Application Segment:
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics
Acute Myeloid Leukemia Market Analysis By Regions (Countries):
The Acute Myeloid Leukemia Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Acute Myeloid Leukemia Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Acute Myeloid Leukemia Market:
Acute Myeloid Leukemia market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Acute Myeloid Leukemia Market status and future forecast.
To present the key Acute Myeloid Leukemia Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Acute Myeloid Leukemia Market Size Growth Rate by Type (2016-2027)
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Stem Cell Transplant
1.4.5 Targeted Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Acute Myeloid Leukemia Market Share by Application (2016-2027)
1.5.2 Hospital
1.5.3 Retails Drug Stores
1.5.4 Ambulatory Care Centers
1.5.5 Oncology Centers
1.5.6 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Acute Myeloid Leukemia Market Size
2.2 Acute Myeloid Leukemia Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia Market Size by Regions (2016-2027)
2.2.2 Acute Myeloid Leukemia Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Acute Myeloid Leukemia Market Size by Manufacturers
3.1.1 Global Acute Myeloid Leukemia Revenue by Manufacturers (2020)
3.1.2 Global Acute Myeloid Leukemia Revenue Market Share by Manufacturers (2020)
3.1.3 Global Acute Myeloid Leukemia Market Concentration Ratio (CR5 and HHI)
3.2 Acute Myeloid Leukemia Key Players Head office and Area Served
3.3 Key Players Acute Myeloid Leukemia Product/Solution/Service
3.4 Date of Enter into Acute Myeloid Leukemia Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Acute Myeloid Leukemia Market Size by Type (2016-2020)
4.2 Global Acute Myeloid Leukemia Market Size by Application (2016-2020)
5 United States
5.1 United States Acute Myeloid Leukemia Market Size (2016-2020)
5.2 Acute Myeloid Leukemia Key Players in United States
5.3 United States Acute Myeloid Leukemia Market Size by Type
5.4 United States Acute Myeloid Leukemia Market Size by Application
6 Europe
6.1 Europe Acute Myeloid Leukemia Market Size (2016-2020)
6.2 Acute Myeloid Leukemia Key Players in Europe
6.3 Europe Acute Myeloid Leukemia Market Size by Type
6.4 Europe Acute Myeloid Leukemia Market Size by Application
7 China
7.1 China Acute Myeloid Leukemia Market Size (2016-2020)
7.2 Acute Myeloid Leukemia Key Players in China
7.3 China Acute Myeloid Leukemia Market Size by Type
7.4 China Acute Myeloid Leukemia Market Size by Application
8 Japan
8.1 Japan Acute Myeloid Leukemia Market Size (2016-2020)
8.2 Acute Myeloid Leukemia Key Players in Japan
8.3 Japan Acute Myeloid Leukemia Market Size by Type
8.4 Japan Acute Myeloid Leukemia Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Acute Myeloid Leukemia Market Size (2016-2020)
9.2 Acute Myeloid Leukemia Key Players in Southeast Asia
9.3 Southeast Asia Acute Myeloid Leukemia Market Size by Type
9.4 Southeast Asia Acute Myeloid Leukemia Market Size by Application
10 India
10.1 India Acute Myeloid Leukemia Market Size (2016-2020)
10.2 Acute Myeloid Leukemia Key Players in India
10.3 India Acute Myeloid Leukemia Market Size by Type
10.4 India Acute Myeloid Leukemia Market Size by Application
11 Central & South America
11.1 Central & South America Acute Myeloid Leukemia Market Size (2016-2020)
11.2 Acute Myeloid Leukemia Key Players in Central & South America
11.3 Central & South America Acute Myeloid Leukemia Market Size by Type
11.4 Central & South America Acute Myeloid Leukemia Market Size by Application
12 International Players Profiles
12.1 Celgene Corporation
12.1.1 Celgene Corporation Company Details
12.1.2 Company Description and Business Overview
12.1.3 Acute Myeloid Leukemia Introduction
12.1.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2020)
12.1.5 Celgene Corporation Recent Development
12.2 Cephalon
12.2.1 Cephalon Company Details
12.2.2 Company Description and Business Overview
12.2.3 Acute Myeloid Leukemia Introduction
12.2.4 Cephalon Revenue in Acute Myeloid Leukemia Business (2020)
12.2.5 Cephalon Recent Development
12.3 Clavis Pharma
12.3.1 Clavis Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Acute Myeloid Leukemia Introduction
12.3.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2020)
12.3.5 Clavis Pharma Recent Development
12.4 Eisai
12.4.1 Eisai Company Details
12.4.2 Company Description and Business Overview
12.4.3 Acute Myeloid Leukemia Introduction
12.4.4 Eisai Revenue in Acute Myeloid Leukemia Business (2020)
12.4.5 Eisai Recent Development
12.5 Genzyme Corporation
12.5.1 Genzyme Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Acute Myeloid Leukemia Introduction
12.5.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2020)
12.5.5 Genzyme Corporation Recent Development
12.6 Sunesis Pharmaceuticals
12.6.1 Sunesis Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Acute Myeloid Leukemia Introduction
12.6.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2020)
12.6.5 Sunesis Pharmaceuticals Recent Development
12.7 Abbvie
12.7.1 Abbvie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Acute Myeloid Leukemia Introduction
12.7.4 Abbvie Revenue in Acute Myeloid Leukemia Business (2020)
12.7.5 Abbvie Recent Development
12.8 Astellas Pharma
12.8.1 Astellas Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Acute Myeloid Leukemia Introduction
12.8.4 Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2020)
12.8.5 Astellas Pharma Recent Development
12.9 CTI Biopharma Corp
12.9.1 CTI Biopharma Corp Company Details
12.9.2 Company Description and Business Overview
12.9.3 Acute Myeloid Leukemia Introduction
12.9.4 CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2020)
12.9.5 CTI Biopharma Corp Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Acute Myeloid Leukemia Key Market Segments
Table Key Players Acute Myeloid Leukemia Covered
Table Global Acute Myeloid Leukemia Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Acute Myeloid Leukemia Market Size Market Share by Type 2016-2027
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Stem Cell Transplant Figures
Table Key Players of Stem Cell Transplant
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Others Figures
Table Key Players of Others
Table Global Acute Myeloid Leukemia Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospital Case Studies
Figure Retails Drug Stores Case Studies
Figure Ambulatory Care Centers Case Studies
Figure Oncology Centers Case Studies
Figure Clinics Case Studies
Figure Acute Myeloid Leukemia Report Years Considered
Table Global Acute Myeloid Leukemia Market Size 2016-2027 (Million US$)
Figure Global Acute Myeloid Leukemia Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Acute Myeloid Leukemia Market Size by Regions 2016-2027 (Million US$)
Table Global Acute Myeloid Leukemia Market Size by Regions 2016-2020 (Million US$)
Table Global Acute Myeloid Leukemia Market Share by Regions 2016-2020
Figure Global Acute Myeloid Leukemia Market Share by Regions 2016-2020
Figure Global Acute Myeloid Leukemia Market Share by Regions 2020
Table Market Top Trends
Table Global Acute Myeloid Leukemia Revenue by Manufacturers (2020) (Million US$)
Table Global Acute Myeloid Leukemia Market Share by Manufacturers (2020)
Figure Global Acute Myeloid Leukemia Market Share by Manufacturers in 2020
Table Global Acute Myeloid Leukemia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Acute Myeloid Leukemia Product/Solution/Service
Table Date of Enter into Acute Myeloid Leukemia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Acute Myeloid Leukemia Market Size by Type (2016-2020) (Million US$)
Table Global Acute Myeloid Leukemia Market Size Share by Type (2016-2020)
Figure Global Acute Myeloid Leukemia Market Size Market Share by Type (2016-2020)
Table Global Acute Myeloid Leukemia Market Size by Application (2016-2020) (Million US$)
Table Global Acute Myeloid Leukemia Market Size Share by Application (2016-2020)
Figure Global Acute Myeloid Leukemia Market Size Market Share by Application (2016-2020)
Figure Global Acute Myeloid Leukemia Revenue Market Share by Application in 2020
Figure United States Acute Myeloid Leukemia Market Size 2016-2020 (Million US$)
Table United States Key Players Acute Myeloid Leukemia Revenue (2020) (Million US$)
Table United States Key Players Acute Myeloid Leukemia Market Share (2020)
Table United States Acute Myeloid Leukemia Market Size by Type (2016-2020) (Million US$)
Table United States Acute Myeloid Leukemia Market Share by Type (2016-2020)
Table United States Acute Myeloid Leukemia Market Size by Application (2016-2020) (Million US$)
Table United States Acute Myeloid Leukemia Market Share by Application (2016-2020)
Figure Europe Acute Myeloid Leukemia Market Size 2016-2020 (Million US$)
Table Europe Key Players Acute Myeloid Leukemia Revenue (2020) (Million US$)
Table Europe Key Players Acute Myeloid Leukemia Market Share (2020)
Table Europe Acute Myeloid Leukemia Market Size by Type (2016-2020) (Million US$)
Table Europe Acute Myeloid Leukemia Market Share by Type (2016-2020)
Table Europe Acute Myeloid Leukemia Market Size by Application (2016-2020) (Million US$)
Table Europe Acute Myeloid Leukemia Market Share by Application (2016-2020)
Figure China Acute Myeloid Leukemia Market Size 2016-2020 (Million US$)
Table China Key Players Acute Myeloid Leukemia Revenue (2020) (Million US$)
Table China Key Players Acute Myeloid Leukemia Market Share (2020)
Table China Acute Myeloid Leukemia Market Size by Type (2016-2020) (Million US$)
Table China Acute Myeloid Leukemia Market Share by Type (2016-2020)
Table China Acute Myeloid Leukemia Market Size by Application (2016-2020) (Million US$)
Table China Acute Myeloid Leukemia Market Share by Application (2016-2020)
Figure Japan Acute Myeloid Leukemia Market Size 2016-2020 (Million US$)
Table Japan Key Players Acute Myeloid Leukemia Revenue (2020) (Million US$)
Table Japan Key Players Acute Myeloid Leukemia Market Share (2020)
Table Japan Acute Myeloid Leukemia Market Size by Type (2016-2020) (Million US$)
Table Japan Acute Myeloid Leukemia Market Share by Type (2016-2020)
Table Japan Acute Myeloid Leukemia Market Size by Application (2016-2020) (Million US$)
Table Japan Acute Myeloid Leukemia Market Share by Application (2016-2020)
Figure Southeast Asia Acute Myeloid Leukemia Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Acute Myeloid Leukemia Revenue (2020) (Million US$)
Table Southeast Asia Key Players Acute Myeloid Leukemia Market Share (2020)
Table Southeast Asia Acute Myeloid Leukemia Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Acute Myeloid Leukemia Market Share by Type (2016-2020)
Table Southeast Asia Acute Myeloid Leukemia Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Acute Myeloid Leukemia Market Share by Application (2016-2020)
Figure India Acute Myeloid Leukemia Market Size 2016-2020 (Million US$)
Table India Key Players Acute Myeloid Leukemia Revenue (2020) (Million US$)
Table India Key Players Acute Myeloid Leukemia Market Share (2020)
Table India Acute Myeloid Leukemia Market Size by Type (2016-2020) (Million US$)
Table India Acute Myeloid Leukemia Market Share by Type (2016-2020)
Table India Acute Myeloid Leukemia Market Size by Application (2016-2020) (Million US$)
Table India Acute Myeloid Leukemia Market Share by Application (2016-2020)
Figure Central & South America Acute Myeloid Leukemia Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Acute Myeloid Leukemia Revenue (2020) (Million US$)
Table Central & South America Key Players Acute Myeloid Leukemia Market Share (2020)
Table Central & South America Acute Myeloid Leukemia Market Size by Type (2016-2020) (Million US$)
Table Central & South America Acute Myeloid Leukemia Market Share by Type (2016-2020)
Table Central & South America Acute Myeloid Leukemia Market Size by Application (2016-2020) (Million US$)
Table Central & South America Acute Myeloid Leukemia Market Share by Application (2016-2020)
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2020) (Million US$)
Figure Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table Celgene Corporation Recent Development
Table Cephalon Company Details
Table Cephalon Revenue in Acute Myeloid Leukemia Business (2020)(Million US$)
Figure Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table Cephalon Recent Development
Table Clavis Pharma Company Details
Table Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2020)(Million US$)
Figure Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table Clavis Pharma Recent Development
Table Eisai Company Details
Table Eisai Revenue in Acute Myeloid Leukemia Business (2020)(Million US$)
Figure Eisai Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table Eisai Recent Development
Table Genzyme Corporation Company Details
Table Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2020)(Million US$)
Figure Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table Genzyme Corporation Recent Development
Table Sunesis Pharmaceuticals Company Details
Table Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2020)(Million US$)
Figure Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table Sunesis Pharmaceuticals Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in Acute Myeloid Leukemia Business (2020)(Million US$)
Figure Abbvie Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table Abbvie Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2020)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table Astellas Pharma Recent Development
Table CTI Biopharma Corp Company Details
Table CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2020)(Million US$)
Figure CTI Biopharma Corp Revenue Growth Rate in Acute Myeloid Leukemia Business (2020)
Table CTI Biopharma Corp Recent Development
Table Global Acute Myeloid Leukemia Market Size by Regions (Million US$) 2021-2027
Figure Global Acute Myeloid Leukemia Market Size Share by Regions (2021-2027)
Figure Global Acute Myeloid Leukemia Market Size Share by Regions in 2027
Figure United States Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure Europe Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure China Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure Japan Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure India Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Acute Myeloid Leukemia Market Size Forecast (2021-2027)(Million USD)
Table Global Acute Myeloid Leukemia Market Size by Product (2021-2027) (Million US$)
Figure Global Acute Myeloid Leukemia Market Size by Product (2021-2027)
Figure Global Acute Myeloid Leukemia Market Size by Product in 2027
Table Global Acute Myeloid Leukemia Market Size by Application (2021-2027) (Million US$)
Figure Global Acute Myeloid Leukemia Market Size by Application (2021-2027)
Figure Global Acute Myeloid Leukemia Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources